Brazilian Pharmaceuticals & Biotech Undervalued based on future growth

Results

1 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Hypera

Market Cap: R$16.3b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$25.74

2.8%

24.5%

Blau Farmacêutica

Market Cap: R$2.3b

A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

BLAU3

R$12.77

1.9%

-18.4%